Access to over 1,500 KOLs to answer key questions to inform development, commercial, or treatment landscape strategy. SAI Experts are available to support KOL selection and can facilitate interviews or conduct blinded interviews.
Mapping of KOL industry affiliations to drive advisory board construction, help select clinical trial sites, and inform KOL interactions and engagement strategy
Identify key partners to support development and clinical trial execution considering expertise, geography, ongoing trials, disclosures, and landscape
Provides feedback on data and changing treatment paradigms and can be performed at conferences for real-time reactions or outside of conferences